Addus HomeCare Co. (NASDAQ:ADUS) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of Addus HomeCare Co. (NASDAQ:ADUSGet Free Report) have earned an average recommendation of “Moderate Buy” from the nine research firms that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, seven have assigned a buy rating and one has issued a strong buy rating on the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $131.38.

Several analysts have issued reports on ADUS shares. TD Cowen raised their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research note on Thursday, August 8th. Royal Bank of Canada reissued an “outperform” rating and set a $141.00 price target on shares of Addus HomeCare in a research note on Tuesday, September 3rd. Oppenheimer upped their price objective on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. StockNews.com lowered Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 7th. Finally, KeyCorp started coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 target price for the company.

Check Out Our Latest Stock Report on ADUS

Insider Activity at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares in the company, valued at $961,687.35. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now directly owns 3,366 shares of the company’s stock, valued at approximately $429,165. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 22,917 shares of company stock worth $3,050,082 over the last three months. 4.60% of the stock is owned by corporate insiders.

Institutional Trading of Addus HomeCare

A number of institutional investors have recently modified their holdings of the company. Texas Permanent School Fund Corp raised its stake in shares of Addus HomeCare by 0.6% during the 2nd quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock worth $1,636,000 after acquiring an additional 82 shares in the last quarter. Arizona State Retirement System increased its position in shares of Addus HomeCare by 2.0% during the second quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock worth $527,000 after purchasing an additional 87 shares in the last quarter. UMB Bank n.a. lifted its holdings in shares of Addus HomeCare by 64.2% during the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after purchasing an additional 88 shares during the last quarter. Inspire Investing LLC boosted its position in shares of Addus HomeCare by 3.3% in the 3rd quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock worth $414,000 after purchasing an additional 100 shares in the last quarter. Finally, Azzad Asset Management Inc. ADV boosted its position in shares of Addus HomeCare by 1.3% in the 2nd quarter. Azzad Asset Management Inc. ADV now owns 8,436 shares of the company’s stock worth $980,000 after purchasing an additional 110 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Stock Performance

NASDAQ:ADUS opened at $130.08 on Friday. The firm has a market capitalization of $2.35 billion, a PE ratio of 32.28, a PEG ratio of 2.33 and a beta of 1.04. The stock’s fifty day moving average is $130.61 and its 200 day moving average is $118.77. Addus HomeCare has a fifty-two week low of $78.35 and a fifty-two week high of $136.12.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last announced its earnings results on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.14. The business had revenue of $286.90 million for the quarter, compared to the consensus estimate of $284.90 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. During the same quarter in the prior year, the firm posted $0.94 earnings per share. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. Equities analysts forecast that Addus HomeCare will post 4.58 EPS for the current year.

About Addus HomeCare

(Get Free Report

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Stories

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.